Celularity Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Celularity Inc. (CELU) on May 1, 2025, regarding an event that occurred on April 30, 2025. The company is incorporated in Delaware and its Class A Common Stock and Warrants trade on The Nasdaq Stock Market LLC.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, or margin data. The only specific financial figure disclosed is a past due fee balance of $70,000 owed to Nasdaq, which has now been settled.
Material Changes
The primary material event reported is the resolution of a listing compliance issue. Celularity notified Nasdaq that the $70,000 past due fee balance was paid in full. Consequently, the company has regained compliance with Nasdaq Listing Rule 5250(f), and the matter is officially closed.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future operations, or discussion of new risks and contingencies beyond the resolution of the specific listing fee delinquency.
Key Facts for Investors to Verify
- Confirmation that the $70,000 fee payment has been processed and the listing compliance status is active.
- Review of recent 10-Q or 10-K filings to assess the company's overall liquidity and ability to meet ongoing exchange fees.
- Verification of the current trading status of CELU and CELUW on Nasdaq following the compliance restoration.